CMS (Centers for Medicare and Medicaid Services) set to review LVADs, burns reimbursement rates
This article was originally published in Clinica
Executive Summary
The Centers for Medicare & Medicaid Services is contemplating raising the reimbursement rate for left ventricular assist devices intended for permanent implantation. The agency announced this week that it would like to reassign LVADs intended for such destination therapy to DRG (diagnosis related group) 103, now used for heart transplants.